(Reuters) - The drug maker said Januvia is the first and only medication in the class of drugs called dipeptidyl peptidase-4 inhibitors, which enhance the body's ability to lower blood sugar when it is elevated, to be adopted by the European Commission.
Read more at Reuters.com Government Filings News
Read more at Reuters.com Government Filings News
No comments:
Post a Comment